Myriad Genetics Inc
XBER:MYD

Watchlist Manager
Myriad Genetics Inc Logo
Myriad Genetics Inc
XBER:MYD
Watchlist
Price: 5.5 EUR -2.65%
Market Cap: 494.5m EUR

Intrinsic Value

The intrinsic value of one MYD stock under the Base Case scenario is 14.4 EUR. Compared to the current market price of 5.5 EUR, Myriad Genetics Inc is Undervalued by 62%.

The Intrinsic Value is calculated as the average of DCF and Relative values:

MYD Intrinsic Value
14.4 EUR
Undervaluation 62%
Intrinsic Value
Price
Worst Case
Base Case
Best Case

Valuation History
Myriad Genetics Inc

What is Valuation History?
Ask AI Assistant
What other research platforms think about MYD?

Let our AI compare Alpha Spread’s intrinsic value with external valuations from Simply Wall St, GuruFocus, ValueInvesting.io, Seeking Alpha, and others.

Discover External Valuations
Why is MYD valued this way?

Let our AI break down the key assumptions behind the intrinsic value calculation for Myriad Genetics Inc.

Explain Valuation
Compare MYD to

Fundamental Analysis

Company Overview
Loading...
Business Segments
Loading...
Economic Moat
Loading...
Earnings Call
Loading...
Management
Loading...
Contacts
Loading...
How do you feel about MYGN?
Bearish
Neutral
Bullish
Financials
Annual
Quarterly
TTM
Annual
Quarterly
TTM

Balance Sheet Decomposition
Myriad Genetics Inc

Current Assets 344.8m
Cash & Short-Term Investments 145.4m
Receivables 118m
Other Current Assets 81.4m
Non-Current Assets 383.3m
PP&E 162m
Intangibles 214.7m
Other Non-Current Assets 6.6m
Current Liabilities 148m
Accounts Payable 31.8m
Accrued Liabilities 86.8m
Other Current Liabilities 29.4m
Non-Current Liabilities 207.3m
Long-Term Debt 119.5m
Other Non-Current Liabilities 87.8m
Efficiency

Free Cash Flow Analysis
Myriad Genetics Inc

Last Value
3-Years Average
FCF Margin
Conversion Rate

Earnings Waterfall
Myriad Genetics Inc

Revenue
825.3m USD
Cost of Revenue
-244.6m USD
Gross Profit
580.7m USD
Operating Expenses
-662.8m USD
Operating Income
-82.1m USD
Other Expenses
-318.4m USD
Net Income
-400.5m USD
Fundamental Scores

MYD Profitability Score
Profitability Due Diligence

Myriad Genetics Inc's profitability score is 23/100. The higher the profitability score, the more profitable the company is.

Exceptional Gross Margin
Strong 3Y Average Gross Margin
Declining Gross Margin
Declining Operating Margin
23/100
Profitability
Score

Myriad Genetics Inc's profitability score is 23/100. The higher the profitability score, the more profitable the company is.

MYD Solvency Score
Solvency Due Diligence

Myriad Genetics Inc's solvency score is 40/100. The higher the solvency score, the more solvent the company is.

Low D/E
Short-Term Solvency
Long-Term Solvency
Negative Net Debt
40/100
Solvency
Score

Myriad Genetics Inc's solvency score is 40/100. The higher the solvency score, the more solvent the company is.

Wall St
Price Targets

MYD Price Targets Summary
Myriad Genetics Inc

Wall Street analysts forecast MYD stock price to rise over the next 12 months.

According to Wall Street analysts, the average 1-year price target for MYD is 6.96 EUR with a low forecast of 2.99 EUR and a high forecast of 15.99 EUR.

Lowest
Price Target
2.99 EUR
46% Downside
Average
Price Target
6.96 EUR
26% Upside
Highest
Price Target
15.99 EUR
191% Upside
View Analyst Estimates
View Analyst Estimates

Dividends

Dividend Yield
Lowest
Average
Highest
Dividend Per Share
N/A
Growth 3Y
Growth 5Y
Growth 10Y
Dividend Safety Score
Very
Unsafe
Unsafe
Safe
Very
Safe
0
25
50
75
100
Shareholder Yield

Current shareholder yield for MYGN is .

Shareholder yield represents the total return a company provides to its shareholders, calculated as the sum of dividend yield, buyback yield, and debt paydown yield. What is shareholder yield?

Shareholder Yield
Dividend Yield
Lowest
Average
Highest
Buyback Yield
Lowest
Average
Highest
Debt Paydown Yield
Lowest
Average
Highest

Competitive Landscape

Company Market Cap Intrinsic Valuation Profitability Solvency Price Change
1Y 3Y 5Y

Ownership

MYGN Insider Trading
Buy and sell transactions by insiders

MYD News

Other Videos
What is the Intrinsic Value of one MYD stock?

The intrinsic value of one MYD stock under the Base Case scenario is 14.4 EUR.

Is MYD stock undervalued or overvalued?

Compared to the current market price of 5.5 EUR, Myriad Genetics Inc is Undervalued by 62%.

Back to Top